Kla-Tencor Corp (KLAC) 67.12 $KLAC These 3 Stocks Led

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kla-Tencor Corp (KLAC) 67.12 $KLAC

These 3 Stocks Led the S&P 500 Higher in October
Dan Caplinger, The Motley Fool - Motley Fool - Sat Oct 31, 11:20PM CDT
The  S&P 500  roared back from its poor performance during the summer, climbing more than 8% to finish the month of October at 2,079. Yet within the S&P 500, some stocks had a greater influence on the index's gains than others. In...
TRIP: 83.78 (+2.85), KLAC: 67.12 (+0.80), SNDK: 77.00 (-0.22)

The 10 Best S&P 500 Stocks in October
at The Street - Fri Oct 30, 3:22PM CDT
The S&P 500 Index rose 8.3% in October, snapping back from its third-quarter lull from extreme global market volatility. Here are the 10 best-performing stocks this month.
YHOO: 35.62 (+0.57), FSLR: 57.07 (+6.08), RIG: 15.83 (+0.56), TRIP: 83.78 (+2.85), DD: 63.40 (+0.06), WYNN: 69.95 (+0.05), KLAC: 67.12 (+0.80), ADSK: 55.19 (+0.13), SNDK: 77.00 (-0.22), URI: 74.86 (+0.60)

Uptrend Call Working As Kla-Tencor Stock Rises 25.9% (KLAC)
Comtex SmarTrend(R) - Thu Oct 29, 12:12PM CDT
SmarTrend identified an Uptrend for Kla-Tencor (NASDAQ:KLAC) on October 6th, 2015 at $51.86. In approximately 3 weeks, Kla-Tencor has returned 25.95% as of today's recent price of $65.31.
KLAC: 67.12 (+0.80)

Kla-Tencor Has Returned 26.6% Since SmarTrend Recommendation (KLAC)
Comtex SmarTrend(R) - Thu Oct 29, 11:01AM CDT
SmarTrend identified an Uptrend for Kla-Tencor (NASDAQ:KLAC) on October 6th, 2015 at $51.86. In approximately 3 weeks, Kla-Tencor has returned 26.58% as of today's recent price of $65.64.
KLAC: 67.12 (+0.80)

Texas Instruments Might Toe M&A Water With Maxim
at Investor's Business Daily - Wed Oct 28, 2:44PM CDT
Texas Instruments (TXN) and Analog Devices (ADI) could grapple for Maxim Integrated Products (MXIM), which is rumored to be on the sales block amid heavy chip industry M&A action. Maxim stock was up 7% Wednesday afternoon on a report that Texas...
MXIM: 40.98 (+0.19), SWKS: 77.24 (+2.61), BRCM: 51.40 (+0.40), ALTR: 52.55 (-0.11), MSCC: 36.01 (-0.77), PMCS: 11.92 (+0.28), INTC: 33.86 (-0.17), WDC: 66.82 (-1.00), LRCX: 76.59 (+0.75), TXN: 56.72 (+0.15), ADI: 60.12 (+0.14), EMC: 26.22 (+0.06), KLAC: 67.12 (+0.80), AAPL: 119.50 (-1.03), SNDK: 77.00 (-0.22), AVGO: 123.13 (+3.04)

Chipmaker Inphi Shoots Up On Doubled Q3 Earnings
at Investor's Business Daily - Wed Oct 28, 12:25PM CDT
Inphi (IPHI) stock gapped up Wednesday on Wall Street after the chipmaker reported Q3 earnings that, for the eighth consecutive quarter, more than doubled year over year. And at least one analyst now sees Inphi as a potential M&A target. For its...
CAVM: 70.95 (+1.79), IPHI: 29.77 (+0.13), ALTR: 52.55 (-0.11), MPWR: 62.42 (+0.69), IDTI: 25.50 (+1.17), WDC: 66.82 (-1.00), INTC: 33.86 (-0.17), LRCX: 76.59 (+0.75), ARMH: 47.43 (+0.08), KLAC: 67.12 (+0.80), AAPL: 119.50 (-1.03), SNDK: 77.00 (-0.22), AVGO: 123.13 (+3.04)

KLA Tops Q1 Earnings Estimates, to Merge with Lam Research
Sejuti Banerjea - Zacks Investment Research - Wed Oct 28, 12:10PM CDT
Last week, KLA-Tencor Corporation (KLAC) reported first-quarter 2016 earnings of 77 cents a share that beat the Zacks Consensus Estimate. The company also announced its merger with Lam Research Corp.
LRCX: 76.59 (+0.75), FB: 101.97 (-2.91), MEET: 2.57 (+0.05), KLAC: 67.12 (+0.80)

KLA-Tencor (KLAC) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Wed Oct 28, 7:03AM CDT
As of late, it has definitely been a great time to be an investor in KLA-Tencor Corp (KLAC)
KLAC: 67.12 (+0.80)

KLA-TENCOR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of KLA-Tencor Corporation (KLAC) Over the Proposed Sale of the Company to Lam Research
PR Newswire - Mon Oct 26, 11:43AM CDT
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of KLA-Tencor Corporation ("KLA-Tencor" or the "Company" (NasdaqGS:KLAC) for potential breaches of fiduciary duties in connection with the sale of the Company to Lam Research for approximately $10.6 billion in a cash and common stock transaction.
LRCX: 76.59 (+0.75), KLAC: 67.12 (+0.80)

Downgrade Alert for Kla-Tencor (KLAC)
Comtex SmarTrend(R) - Mon Oct 26, 7:09AM CDT
Kla-Tencor (NASDAQ:KLAC) was downgraded from Buy to Neutral at Nomura today. The stock closed yesterday at $65.35 on volume of 8.4 million shares, above average daily volume of 3.0 million. Based on a current price of $65.35, Kla-Tencor is currently 1.6% above its average consensus analyst price target of $64.31. The stock should discover initial support at its 200-day moving average (MA) of $57.30 and subsequent support at its 50-day MA of $51.24.
KLAC: 67.12 (+0.80)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of KLA-Tencor Corporation
Business Wire - Fri Oct 23, 9:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of KLA-Tencor Corporation ("KLA-Tencor" or "the Company" (Nasdaq: KLAC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Lam Research.
LRCX: 76.59 (+0.75), KLAC: 67.12 (+0.80)

EQUITY ALERT: Rosen Law Firm Announces Investigation of KLA-Tencor Corporation Concerning its Proposed Sale to Lam Research Corporation - KLAC
Business Wire - Fri Oct 23, 4:41PM CDT
Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of KLA-Tencor Corporation (NASDAQ:KLAC) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop KLA-Tencor to maximize shareholder value before agreeing to be acquired by Lam Research Corporation (NASDAQ:LRCX).
LRCX: 76.59 (+0.75), KLAC: 67.12 (+0.80)

KLA-Tencor Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR Newswire - Fri Oct 23, 3:02PM CDT
Securities lawyers at Dunnam & Dunnam are investigating the board of KLA-Tencor (NASDAQ: KLAC) in connection with a buyout for only $67.02 per share in cash and stock. Concerned KLAC investors are encouraged to contact attorney Hamilton Lindley by clicking here.
KLAC: 67.12 (+0.80)

Harwood Feffer LLP Announces Investigation of KLA-Tencor Corporation
PR Newswire - Fri Oct 23, 1:58PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of KLA-Tencor Corporation ("KLA-Tencor" or the "Company" (NASDAQ: KLAC) concerning the proposed acquisition of the Company by affiliates of Lam Research Corporation ("Lam".
LRCX: 76.59 (+0.75), KLAC: 67.12 (+0.80)

KLA-TENCOR CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Lam Research
Business Wire - Fri Oct 23, 1:30PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of KLA-Tencor Corporation ("KLA-Tencor" (NASDAQ: KLAC) concerning the sale to Lam Research (NASDAQ: LRCX). Under the terms of the agreement, KLA-Tencor shareholders will only receive $32.00 in cash and 0.5 of a share of LRCX for each share of KLA-Tencor common stock owned, the total value of which is approximately $67.02.
LRCX: 76.59 (+0.75), KLAC: 67.12 (+0.80)

Lam Research (LRCX) Q1 Earnings Beat, Revenues In Line
Zacks Equity Research - Zacks Investment Research - Fri Oct 23, 12:35PM CDT
Lam Research delivered modest fiscal first quarter 2016 results with earnings beating the Zacks Consensus Estimate and revenues meeting the same.
AMZN: 625.90 (-0.65), LRCX: 76.59 (+0.75), KLAC: 67.12 (+0.80), AAPL: 119.50 (-1.03)

Fitch Places KLA-Tencor's 'BBB-' Rating on Watch Positive on Merger with Lam Research
Business Wire - Thu Oct 22, 4:36PM CDT
Fitch Ratings has placed the ratings for KLA-Tencor Corporation (KLA-Tencor), including the 'BBB-' long-term Issuer Default Rating (IDR), on Rating Watch Positive. The action follows the company's announcement of a planned merger with Lam Research Corp (Lam).
LRCX: 76.59 (+0.75), KLAC: 67.12 (+0.80)

SanDisk Downgraded After Megadeal; eBay Gets New PT
at Investor's Business Daily - Thu Oct 22, 3:23PM CDT
SanDisk (SNDK) got several downgrades Thursday following news of a megadeal with Western Digital (WDC), while eBay (EBAY) and Boeing (BA) both got new price targets and Visa (V) received new analyst coverage. Meanwhile, SolarWinds (SWI) was...
UA: 95.08 (-1.28), SWI: 58.03 (+0.11), V: 77.58 (-0.93), EBAY: 27.90 (-0.27), NKE: 131.03 (-0.09), LRCX: 76.59 (+0.75), RHT: 79.11 (+0.26), GPS: 27.22 (+0.52), KLAC: 67.12 (+0.80), ULTA: 173.96 (+0.66), BA: 148.07 (+0.89), WDC: 66.82 (-1.00), LULU: 49.17 (+0.38), SNDK: 77.00 (-0.22)

KLA-TENCOR CORP. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - Thu Oct 22, 1:53PM CDT
Rigrodsky & Long, P.A.:
LRCX: 76.59 (+0.75), KLAC: 67.12 (+0.80)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 149

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 261

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 337

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 167

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 158

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 242

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 219

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading

Top 5 Most Recently Viewed Articles

Wave, Conservation Nation Fuel Ocean Conservation Efforts

Updated Category News Views 34

Empowering Ocean Regeneration: A Fellowship Initiative Takes Center Stage Amidst the usual chaos that is World Ocean Day, comes a bit of news that's not just lip service. Conservation Nation and Wave have teamed up, rolling out a Fellowship that's got my attention for all the right reasons. This isn’t just another recycled idea being dressed up as an innovation to snag...

Continue Reading
AI Security Challenges: Insights from Coalfire's Innovations

Updated Category News Views 235

Addressing AI Security Challenges in Modern Enterprises As organizations increasingly adopt artificial intelligence (AI) and machine learning (ML) technologies, the imperative for security has never been more critical. Coalfire, a respected name in cybersecurity, reveals significant findings that underscore vulnerabilities in generative and agentic AI applications. The...

Continue Reading
Nio's Onvo L60 Launch Signals Growth for Investors Ahead

Updated Category News Views 159

Nio Introduces the Exciting Onvo L60 SUV Nio has entered the spotlight in the electric vehicle market by launching its newest model, the Onvo L60. This SUV, which has debuted with an eye-catching price, has stirred interest by being priced lower than many in the industry expected. Market Response to Nio's Launch On the day of the launch, shares of Nio jumped by more than...

Continue Reading
Viasat Launches Government Services via ViaSat-3 F1 Satellite

Updated Category News Views 102

Viasat Launches Government Services via ViaSat-3 F1 Satellite Viasat is now providing crucial satellite services to the U.S. Marine Corps using the ViaSat-3 network. This launch marks a significant stride towards enhancing connectivity for government operations. Connecting Military Operations The Marine Wing Communications Squadron 38 (MWCS-38) and the 3rd Marine Littoral...

Continue Reading
Moderna, Inc. Shareholders: Important Class Action Update

Updated Category News Views 68

Moderna, Inc. found itself in the crosshairs back in 2024 when shareholders took action against the biotech giant, alleging serious miscommunication regarding its mRNA-1345 vaccine for respiratory syncytial virus. This lawsuit wasn’t just another legal hurdle; it was a wake-up call for investors who had banked on inflated claims about product efficacy. Shareholder...

Continue Reading